PSI Expands Support for Global Clinical Trials With First Office in Türkiye

Mahall Ankara Turkiye officePSI CRO, 9 July 2024 – PSI CRO has announced the opening of its first office in Ankara, reflecting the company’s commitment to supporting pivotal clinical trials in Türkiye and around the globe.

Turkey’s clinical trial market is expected to grow over the next decade, providing high-quality pivotal data from diverse patient populations. The country’s proximity to key markets in Europe, Asia, and the Middle East makes it ideal for multinational trials, particularly in PSI’s core therapeutic focus areas of oncology, hematology-oncology, gastrointestinal diseases, infectious diseases, CNS, and other areas.

“The opening of our new office in Ankara is a testament to PSI’s ongoing growth in Turkey and our belief in the potential of the local clinical trial market,” said Mehmet Tunali, Clinical Operations Manager at PSI. “We are excited to provide a physical home that not only supports our business objectives but also promotes a positive and productive work environment.”

PSI’s new space is located in the heart of Ankara at Dumlupinar Bul. No: 274/7 Mahall Ankara. This prime location will help PSI’s sponsors unlock Türkiye’s untapped clinical trial potential by providing a space for collaboration and deepening relationships with local investigators, key opinion leaders, and other stakeholders. 

“This move aligns with our dedication to the passionate Turkish life sciences community, fostering stronger connections and driving growth,” said Genka Rizova, Country Manager at PSI.

With over 3,000 staff in 60 countries, PSI is the only CRO of its size still growing organically, offering its employees and customers stability and consistency uncommon among CROs. Explore PSI’s unique CRO offering here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 | ashley.stufanocollins@psi-cro.com

 

 

 

 

 

Share